MTCO2P27

Across TCGA pan-cancer cohorts, MTCO2P27 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MTCO2P27 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher MTCO2P27 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTCO2P27 expression acts as an unfavorable survival marker, although some lineages such as BLCA and UCS show a favorable association.

LIHC, BLCA, and UCS are the cancer types where MTCO2P27 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.426	0.581	<.001	37	view →
BLCA	OS	Median	All	0.687	0.566	.007	20	view →
UCS	OS	Quartile	III,IV	0.765	0.248	.012	16	view →
LAML	DFS	Median	All	0.487	0.267	.002	14	view →
COAD	DFS	Median	II,III,IV	0.597	0.718	.011	9	view →
PAAD	DFS	Median	All	0.397	0.181	.003	6	view →
CHOL	OS	Quartile	II,III,IV	1.000	0.416	.038	6	view →
MESO	DFS	Quartile	III,IV	0.542	0.329	.032	6	view →
LUAD	OS	Median	All	0.426	0.290	.007	6	view →
KICH	DFS	Quartile	III,IV	0.291	0.757	.025	4	view →
SKCM	DFS	Tertile	III,IV	0.378	0.219	.020	3	view →
ACC	OS	Median	All	0.942	0.827	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MTCO2P27–LIHC (DFS)

Open the LIHC breakdown →